At AAIC 2022, Translucence Presented Their Work on Brain-Wide Measurement of Antibody Therapeutics, Microglia and β-Amyloid Plaques

by
Translucence Biosystems
August 3, 2022

Translucence Co-Founders Damian Wheeler, Ph.D. and Sunil Gandhi, Ph.D. along with their colleagues Chase Redd and Nathaniel Guanzon recently presented at the Alzheimer's Association International Conference® 2022. To help move AD drug discovery forward, Translucence has developed whole-brain regional assays for β-Amyloid plaques and microglia and with Lundbeck, methods to measure antibody therapeutics crossing the Blood-Brain Barrier and homing in on their target.

Access the "Brain Wide Monitoring of Antibody Therapeutics Crossing the Blood/Brain Barrier" poster here.

Access the "Brain-Wide Cellular Resolution Regional Quantification of Microglia and Amyloid in 5xfad Mice" poster here.

Ask your question

Send us your questions and we will get back to you as soon as possible
info@translucencebio.com

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

May 4, 2022

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium hosted by the Gavin Herbert Eye Institute at the University of California, Irvine School of Medicine.
by
Angela Prvulovic
September 29, 2021
Achievements

Translucence Biosystems is a 2021 High Tech Awards finalist

Translucence Biosystems is a finalist in the Outstanding Emerging Technology Company category at Octane OC's 2021 High Tech Awards (HTA). Special thanks to University Lab Partners for making our work possible!
by
Damian Wheeler
September 21, 2021
Updates

Co-Founder, Sunil Gandhi Ph.D., presents at Research Innovation Spotlight on Neuroscience hosted by Alliance for SoCal Innovation & BioscienceLA

Sunil Gandhi Ph.D. discusses novel imaging technology that has the potential to dramatically enhance how researchers can locate drug effects in the central nervous system (CNS) for preclinical studies.
by
Angela Prvulovic